e-learning
resources
Milan 2017
Wednesday, 13.09.2017
New perspectives from experimental models of pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bone marrow transplantation reduces susceptibility to pulmonary hypertension in BMPR2 deficient mice
A. Crosby (Cambridge, United Kingdom)
Source:
International Congress 2017 – New perspectives from experimental models of pulmonary hypertension
Session:
New perspectives from experimental models of pulmonary hypertension
Session type:
Oral Presentation
Number:
4661
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Crosby (Cambridge, United Kingdom). Bone marrow transplantation reduces susceptibility to pulmonary hypertension in BMPR2 deficient mice. 4661
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
The definition of pulmonary hypertension: history, practical implications and current controversies
Asbestosis
Related content which might interest you:
Injection of bone marrow cells reduces bleomycin-induced pulmonary fibrosis in mice
Source: Annual Congress 2005 -
In vivo
- approaches to lung injury
Year: 2005
Pulmonary hypertension after bone marrow transplantation in children
Source: Eur Respir J, 54 (5) 1900612; 10.1183/13993003.00612-2019
Year: 2019
Human pulmonary arterial hypertension bone marrow-derived CD133+ myeloid progenitors induce vascular remodeling in immunodeficient mice
Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension
Year: 2011
Alterations of bone marrow derived endothelial progenitor cells following acute pulmonary embolism in mice
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
Pulmonary dysfunction after bone marrow transplantation (BMT) for thalassemia major: long-term results
Source: Eur Respir J 2004; 24: Suppl. 48, 157s
Year: 2004
Implication of bone marrow-derived c-kit positive cells in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension
Year: 2009
Pulmonary involvement in haematological disorders and bone marrow transplant recipients
Source: Eur Respir Monogr 2019; 86: 333-358
Year: 2019
Monitoring of lung function and airways inflammation after bone marrow transplantation
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008
Effects of bone marrow mesenchymal stem cells on bleomycin induced pulmonary fibrosis in rats
Source: Annual Congress 2006 - Pulmonary fibrosis: pathophysiology and therapeutic approaches
Year: 2006
Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
The impact of bone marrow stem cells therapy in pulmonary and extrapulmonary acute lung injury
Source: Annual Congress 2008 - Pathophysiology of acute lung injury
Year: 2008
LATE-BREAKING ABSTRACT: Effect of allogenic bone marrow transplant on cardiac function and pulmonary vascular pressure
Source: Annual Congress 2013 –New physiologic boundaries
Year: 2013
Oral presentation: Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009
Telespirometry for home monitoring of pulmonary function in patients after allogeneic bone marrow transplantation
Source: Eur Respir J 2003; 22: Suppl. 45, 242s
Year: 2003
Expression of the biological axis VEGF-CXCL12/CXCR4 in bone marrow mesenchymal stem cells (BM MSCs) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008
LSC 2010 Abstract: Does cigarette smoking influence bone marrow microenvironment? Down-regulation of CXCR4 expression in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): preliminary results
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Investigation of the participation of bone marrow derived cells in pulmonary angiogenesis and vascular remodeling
Source: Eur Respir J 2002; 20: Suppl. 38, 481s
Year: 2002
Lung transplantation after bone marrow transplantationin paediatric patients
Source: Eur Respir J 2006; 28: Suppl. 50, 725s
Year: 2006
The effect of pulmonary macrophage transplantation in the pulmonary fibrosis of mice
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021
Bone marrow progenitor cells in patients with COPD
Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept